Related references
Note: Only part of the references are listed.The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC-205/CD205 Receptor on Dendritic Cells
Bei Wang et al.
CANCER VACCINES (2009)
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma
Robin J. Prestwich et al.
BJU INTERNATIONAL (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Pauline Verdijk et al.
CLINICAL CANCER RESEARCH (2009)
Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
Aude Bonehill et al.
CLINICAL CANCER RESEARCH (2009)
Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2
Timothy Kottke et al.
CLINICAL CANCER RESEARCH (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical Grade OK432-activated Dendritic Cells In Vitro Characterization and Tracking During Intralymphatic Delivery
Emma West et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide-loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells
Satoshi Fukushima et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization
Frederick Arce et al.
MOLECULAR THERAPY (2009)
Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion
Irina Y. Tcherepanova et al.
BMC MOLECULAR BIOLOGY (2008)
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
Fabian Benencia et al.
CANCER BIOLOGY & THERAPY (2008)
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
A. C. Inge Boullart et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response
Anne Gauvrit et al.
CANCER RESEARCH (2008)
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation
Ravikumar Muthuswamy et al.
CANCER RESEARCH (2008)
Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells
Christopher J. Farrell et al.
CLINICAL CANCER RESEARCH (2008)
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Robin J. Prestwich et al.
CLINICAL CANCER RESEARCH (2008)
The immune system - is it relevant to cancer development, progression and treatment?
R. J. Prestwich et al.
CLINICAL ONCOLOGY (2008)
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma
F. Errington et al.
GENE THERAPY (2008)
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors
J. Qiao et al.
GENE THERAPY (2008)
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
Maria A. Gonzalez-Carmona et al.
HEPATOLOGY (2008)
Reovirus activates human dendritic cells to promote innate antitumor immunity
Fiona Errington et al.
JOURNAL OF IMMUNOLOGY (2008)
Vaccination of prostate cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) - A phase 2 trial
Robert J. Amato et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
Bruce G. Redman et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Adenovirus MART-1 - engineered autologous dendritic cell vaccine for metastatic melanoma
Lisa H. Butterfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
Khoi Q. Tran et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
P. Hersey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
Dendritic cells modified with 6Ckine/IFNγ fusion gene induce specific cytotoxic T lymphocytes in vitro
Gang Xue et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
Sandra Tuyaerts et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells:: APC8015 (Provenge®)
Andrea L. Harzstark et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells
Selina Khan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
Paul J. Sabbatini et al.
CLINICAL CANCER RESEARCH (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells
Kei Tomihara et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
Rosa Maria Diaz et al.
CANCER RESEARCH (2007)
Systemic efficacy with oncolytic virus therapeutics: Clinical proof-of-concept and future directions
Ta-Chiang Liu et al.
CANCER RESEARCH (2007)
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity
Anthony T. Power et al.
MOLECULAR THERAPY (2007)
Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy
Ianko D. Iankov et al.
MOLECULAR THERAPY (2007)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
J. A. Kyte et al.
CANCER GENE THERAPY (2006)
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes
Amelia Grover et al.
CLINICAL CANCER RESEARCH (2006)
Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity
Anna K. Palucka et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Immune suppression in the tumor microenvironment
TF Gajewski et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors
HL Kaufman et al.
HUMAN GENE THERAPY (2006)
Essay - Dendritic cells in a mature age
Caetano Reis e Sousa
NATURE REVIEWS IMMUNOLOGY (2006)
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
N van Baren et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
IJM de Vries et al.
NATURE BIOTECHNOLOGY (2005)
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8
E Feijoó et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Migration of dendritic cell based cancer vaccines:: in vivo veritas?
GJ Adema et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function
R Spörri et al.
NATURE IMMUNOLOGY (2005)
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes
XS Liao et al.
MOLECULAR THERAPY (2004)
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector
A Terando et al.
CANCER GENE THERAPY (2004)
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
P Hersey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin:: Role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets
JC Dudda et al.
JOURNAL OF IMMUNOLOGY (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4
RM Cisco et al.
JOURNAL OF IMMUNOLOGY (2004)
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control
DW Mullins et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors
M Dauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Dendritic cells under the spell of prostaglandins
AE Morelli et al.
TRENDS IN IMMUNOLOGY (2003)
Allogeneic dendritic cells fused with tumor cells:: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
A Märten et al.
HUMAN GENE THERAPY (2003)
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes
F Grünebach et al.
GENE THERAPY (2003)
Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application
HR Bohnenkamp et al.
CYTOTECHNOLOGY (2003)
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-Transfected dendritic cells
SK Nair et al.
ANNALS OF SURGERY (2002)
Tumour escape from immune surveillance through dendritic cell inactivation
AP Vicari et al.
SEMINARS IN CANCER BIOLOGY (2002)
Chemokines and the tissue-specific migration of lymphocytes
EJ Kunkel et al.
IMMUNITY (2002)
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
MA Morse et al.
JOURNAL OF GASTROINTESTINAL CANCER (2002)
Dendritic cells injected via different routes induce immunity in cancer patients
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient
LM Real et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
A. A. Jungbluth et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
